Current Edition

Drug Accountability and Destruction Reporting – Closing the Clinical Supply Chain Information Loop

Martin Lamb of Biotec Services International proves there are ways in which a little extra time spent on up-front planning of clinical supply accountability can save considerable time and cost at the end of a clinical trial. Accountability at the clinical site remains the responsibility of the clinical investigator. While technology solutions exist, largely through IRT systems that can make maintain accountability consistent and easier to track, a surprising number of studies still rely on paper-based accountability logs.